Overexpression of placenta growth factor in human middle ear cholesteatoma

Acta Oto-Laryngologica

Volumn 126, Issue 9, 2006, Pages 900-904

  Cho, Jae Gu ^a   Lim, Hyun Woo ^a   Woo, Jeong Su ^a   Hwang, Soon Jae ^a   Lee, Heung Man ^a   Chae, Sung Won ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Angiogenesis; Cholesteatoma; Placenta growth factor

Indexed keywords

MESSENGER RNA; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR;

ARTICLE; CHOLESTEATOMA; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MIDDLE EAR; NEOVASCULARIZATION (PATHOLOGY); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CHOLESTEATOMA, MIDDLE EAR; EAR, MIDDLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 39049183197     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480500546334     Document Type: Article

References (14)

1. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-9.
2. Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, Baird A, et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 2000;21:793-8.
3. Kendall RL, Wang G, DiSalvo J, Thomas KA. Specificity of vascular endothelial cell growth factor receptor ligand binding domains. Biochem Biophys Res Commun 1994;201:326-30.
4. Carmeliet P, Moons L, Luttun A, Vincenti V, Compemolle V, De Mol M, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001;7:575-83.
5. De Falco S, Gigante B, Persico MG. Structure and function of placental growth factor. Trends Cardiovasc Med 2002;12:241-6.
6. Khaliq A, Li XF, Shams M, Sisi P, Acevedo CA, Whittle MJ, et al. Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors 1996;13:243-50.
7. Matsumoto K, Suzuki K, Koike H, Hasumi M, Matsui H, Okugi H, et al. Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia. Anticancer Res 2003;23:3767-73.
8. Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, et al. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 1995;11:1569-79.
9. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 1994;54:4233-7.
10. Nomura M, Yamagishi S, Harada S, Yamashima T, Yamashita J, Yamamoto H. Placenta growth factor (PlGF) mRNA expression in brain tumors. J Neurooncol 1998;40:123-30.
11. Failla CM, Odorisio T, Cianfarani F, Schietroma C, Puddu P, Zambruno G. Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol 2000;115:388-95.
12. Shiwa M, Kojima H, Moriyama H. Expression of transforming growth factor-alpha (TGF-alpha) in cholesteatoma. J Laryngol Otol 1998;112:750-4.
13. Kato A, Ohashi Y, Masamoto T, Sakamoto H, Uekawa M, Nakai Y. Interleukin-6 and tumour necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the eustachian tube. Acta Otolaryngol Suppl 1998;538:90-7.
14. Naim R, Riedel F, Gotte K, Bran G, Sodick H, Gossler U, et al. Co-expression of different angiogenic factors in external auditory canal cholesteatoma. Acta Otolaryngol (Stockh) 2004;124:563-8.